CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 3 filers reported holding CTI BIOPHARMA CORP in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $25,276 | -33.7% | 6,018 | -5.1% | 0.00% | – |
| Q4 2022 | $38,127 | -92.5% | 6,344 | -92.7% | 0.00% | – |
| Q3 2022 | $507,000 | – | 87,068 | +124282.9% | 0.00% | – |
| Q2 2022 | $0 | – | 70 | +311.8% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 17 | -100.0% | 0.00% | – |
| Q3 2018 | $2,051,000 | -70.6% | 949,700 | -32.2% | 0.00% | -100.0% |
| Q2 2018 | $6,972,000 | +27.7% | 1,400,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $5,460,000 | – | 1,400,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 8,800,358 | $21,825,000 | 10.02% |
| CAXTON CORP | 2,239,300 | $5,553,000 | 4.54% |
| Altium Capital Management LP | 2,185,000 | $5,419,000 | 1.49% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,483,829 | $3,680,000 | 1.49% |
| Ghost Tree Capital, LLC | 1,200,000 | $2,976,000 | 1.07% |
| Lion Point Capital, LP | 1,223,595 | $3,034,000 | 0.81% |
| BVF INC/IL | 8,929,690 | $22,146,000 | 0.80% |
| NEA Management Company, LLC | 7,140,450 | $17,708,000 | 0.36% |
| Knott David M Jr | 221,079 | $548,000 | 0.19% |
| Lakeside Advisors, INC. | 97,780 | $242,000 | 0.18% |